Key challenges for next-generation pharmacogenomics

被引：33

作者：

Kampourakis, Kostas ^{[1
,2
]}

Vayena, Effy ^{[3
]}

Mitropoulou, Christina ^{[4
]}

van Schaik, Ron H. ^{[4
]}

Cooper, David N. ^{[5
]}

Borg, Joseph ^{[6
]}

Patrinos, George P. ^{[7
]}

机构：

[1] Univ Geneva, Univ Teacher Training Inst, Geneva, Switzerland

[2] Univ Geneva, Biol Sect, Geneva, Switzerland

[3] Univ Zurich, Inst Biomed Eth, Zurich, Switzerland

[4] Erasmus Univ, Med Ctr, Dept Clin Chem, Rotterdam, Netherlands

[5] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF10 3AX, S Glam, Wales

[6] Univ Malta, Dept Appl Biomed Sci, Msida, Malta

[7] Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece

来源：

EMBO REPORTS | 2014年 / 15卷 / 05期

基金：

欧盟地平线“2020”;

关键词：

GENETICS; HEALTH;

D O I：

10.1002/embr.201438641

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Recent advances in genomics and sequencing technology herald the advent of pharmacogenomics in routine clinical practice. Yet, while science and technology have progressed rapidly, legal, social and ethical challenges remain to be resolved. © 2014 The Authors.

引用

页码：472 / 476

页数：5

共 16 条

[11] Effects of Repeated Exposure to Science TV Shows on Beliefs About Scientific Evidence and Interest in Science [J].